| Display title | Medicine:List of off-label promotion pharmaceutical settlements |
| Default sort key | List of off-label promotion pharmaceutical settlements |
| Page length (in bytes) | 49,275 |
| Namespace ID | 3048 |
| Namespace | Medicine |
| Page ID | 862738 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>S.Timg |
| Date of page creation | 00:19, 5 February 2024 |
| Latest editor | imported>S.Timg |
| Date of latest edit | 00:19, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and... |
